Alkem

Allergan

Astrazeneca

Cadila

Cipla

Dr. Reddy's

Elder

FDC

GSK

Glenmark

Intas

Lupin

Macleods

Mankind

Medley

Nicholas Piramal

Novartis

Pfizer

Ranbaxy

RPG

Sanofi-Aventis

Shalaks

Shreya

Sun

Svizera

Torrent

Unichem

USV

Wallace

Wockhardt

Nicholas Piramal

www.piramalhealthcare.com

Piramal Healthcare Ltd, a Piramal Group company, is a globally integrated healthcare company that fulfills unmet medical needs across the world. It is also one of the largest custom manufacturing companies with a global footprint of assets across North America, Europe and Asia. At Piramal Healthcare, our core values of Knowledge, Action and Care propel us to improve the quality of lives by democratizing healthcare, Piramal Healthcare was the only pharmaceutical company to have a representation on the Scientific Advisory Committee to the Prime Minister of India.

Novartis

www.novartis.com

Novartis was created in 1996 through the merger of Ciba-Geigy and Sandoz, two companies with a rich and diverse corporate history. We want to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life. With approximately 100 000 associates in 140 countries worldwide, Novartis associates share a vision of a better today and tomorrow for patients – a vision that drives our growth and success. Novartis is currently organized into four divisions: Pharmaceuticals, Vaccines and Diagnostics, Sandoz, Consumer Health.

Pfizer

www.pfizer.com

Pfizer was founded by cousins Charles Pfizer and Charles Erhart in 1849. The pursuit of innovation is basic to Pfizer's culture. It shapes our strategy, defines our purpose, and governs every facet of our operations -- from research and development (R&D) that leads to pharmaceutical inventions, to the transfer of knowledge to patients and providers, to the way we respond to the changing marketplace. Pfizer scientists have produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections. And today we're taking on some of the world's most difficult diseases, including cancer, arthritis, and osteoporosis.

Ranbaxy

www.ranbaxy.com

Ranbaxy was incorporated in 1961 and went public in 1973. For the year 2008, the Company recorded Global Sales of US $ 1,682 Mn, reflecting a growth of 4%. Ranbaxy Laboratories Limited (Ranbaxy), India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy today has a presence in 23 of the top 25 pharmaceutical markets of the world. The Company has a global footprint in 46 countries, world-class manufacturing facilities in 7 countries and serves customers in over 125 countries. The new drug research areas at Ranbaxy include anti-infectives, inflammatory / respiratory, metabolic diseases, oncology, urology and anti-malaria therapies.

RPG lifesciences

www.rpglifesciences.com

Khwaja Abdul Hamied, the founder set up The Chemical, Industrial & Pharmaceutical Laboratories, which came to be popularly known as Cipla. On August 17, 1935, Cipla was registered as a public limited company with an authorised capital of Rs 6 lakhs. Cipla was officially opened on September 22, 1937 when the first products were ready for the market.Cipla exports raw materials, intermediates, prescription drugs, OTC products and veterinary products. Cipla products are bought by over 180 countries in world.

Sanofi-Aventis Pharma

www.aventispharmaindia.com

Aventis Pharma Limited was incorporated in May 1956 under the name Hoechst Fedco Pharma Private Limited. Over the years, its name was changed to Hoechst Pharmaceuticals Private Limited, Hoechst India Limited and Hoechst Marion Roussel Limited. Sanofi-aventis, one of the world's leading pharmaceutical companies. Aventis Pharma Limited in India provides medicines for the treatment of patients in several therapeutic areas: Cardiovascular Disease, Thrombotic Diseases, Metabolic Disorders, Oncology, Disorders of the Central Nervous System, Internal medicine.It is present in more than 100 countries, with around 11,000 scientists, we have around 100,000 employees working to improve health and wellbeing. Our Global headquarters are in Paris, France.

Shalaks Labs

www.shalaks.com

Shalaks is an established & experienced company that is manufacturing & marketing finished formulations Drugs & Personal care products. At the time of its inception Shalaks specialized in general specialized prescription medicaments but now the company has expanded rapidly to encompass a range of dermal & skin care products. The philosophy behind Shalaks success lies in our commitment & dedication to provide excellent products at competitive prices and reliable service to all our customers. Our potential capacity through Development strategies enables us to respond quickly to the needs & requirements of the general public. Our primary aim is to continue to fulfill the above objectives to promote product awareness & inform & expand current markets.

Shreya Life Sciences

www.shreya.co.in

Shreya Group origins go back to Moscow, Russia, where Shreya Corporation, the parent company, was established in 1995. Once a one-man trading company, Shreya is today the third largest Marketing & Distribution Company in Russia. Shreya Group has interests in both pharmaceutical and biopharmaceutical products in key therapeutic segments. Currently, Shreya operates in Russia, CIS, India, South East Asia and African countries. The Group turnover for the year 2006 was US $ 581 million including US $ 85 million in India. Shreya Life Sciences, the Indian arm of Shreya Group started its operations in India in the year 2001 by acquiring the Pharma Division of Rallis India Ltd., a TATA Group company. In 2003, Shreya acquired the domestic pharma business of Plethico Pharmaceuticals Ltd., with a view to achieve a full-fledged national presence.

Sun Pharmaceuticals

www.sunpharma.com

Sun Pharma came into existence as a startup with just 5 products in 1983. Products that are used in cardiology were introduced in 1987, and Monotrate, one of the first products launched at that time has since become one of our largest selling products. Important products in Cardiology were then added; several of these were introduced for the first time in India. We are now an international speciality pharma company with over 8000 people, 19 manufacturing locations (including four in the US, one in Hungary and one in Bangladesh), two research centers and a presence in 30 countries. We make speciality pharmaceuticals and active pharmaceutical ingredients. Our brands are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, gastroenterology, diabetology and respiratory.

Svizera Healthcare

www.svizera.com

It is evolved from a small trading activity in 1975 to a highly sophisticated brand of quality and affordable healthcare today. In the year 2004, “Maneesh” Pharmaceuticals acquired Sigma Laboratories, a Rs.65 Cr. company with a good marketing presence in India and is now a part of Rs.250 Cr. group. This was titled as Svizera Healthcare. It plays a very important role in strengthening “Maneesh” Pharmaceuticals in the domestic market. Svizera Healthcare specialises in Gynaecology and Infertility based product mix and is growing with increasing number of high-end products to market in India. Svizera Healthcare further operates with three of its sub-divisions. It has a focus on Quality Manufacturing products for critical therapeutic areas like Anti TB, Anti Malarial, Antibiotics, Pain Management, Infertility and Gynecology.

Torrent Labs

www.torrentpharma.com

Trinity' was renamed 'Torrent' and with this not only did the company get a new name, it also focused on establishing its own manufacturing facilities in the early 80s. Torrent augmented its efforts with the expansion of its manufacturing capacity, emphasis on marketing and creating business opportunities through focus on exports. Torrent Pharmaceuticals Limited recorded a quantum leap in the year 1994.

Unichem Laboratories

www.unichemlabs.com

Headquartered in Mumbai, India, Lupin Limited today is an innovation led transnational pharmaceutical company producing a wide range of quality, affordable generic and branded formulations and APIs for the developed and developing markets of the world. Dr. Desh Bandhu Gupta’s vision and dream to fight life threatening infectious diseases and manufacture drugs of highest national priority led to the formation of Lupin in the year 1968. Lupin first gained recognition when it became one of the world’s largest manufacturers of Tuberculosis drugs. The Company today has significant market share in key markets in the Cardiovascular (prils and statins), Diabetology, Asthma, Pediatrics, CNS, GI, Anti-Infectives and NSAIDs therapy segments, not to mention global leadership positions in the Anti-TB and Cephalosporins segments.

USV

www.usvindia.com

USV is a 48 year old healthcare company which began as a joint venture with USV&P Inc, a subsidiary of Revlon. Our product range consists of Generics, Active Pharmaceutical Ingredients and Biotherapeutics that are manufactured in our modern cGMP compliant plants located in India. We market our products globally to over 40 countries. In financial year 2008-09 our sales were Rs. 8,451 million. Our international business contributes 32% to our sales. Our intellectual property portfolio consists of 77 international patent filings with 24 grants.

Wallace Pharmaceuticals

www.wallacepharma.com

Wallace was formed through a collaboration between Carter Wallace Inc. and Cosme Matias Menezes Pvt. Ltd. in the late 1960's. Wallace is today a wholly Indian company, and has emerged as a leading player in the Indian domestic market. In the international arena, Wallace is also rapidly emerging as a fast growing healthcare solution provider. The aim is to continuously develop and manufacture formulations to complement our current product range of leading brands in the Antibiotic, Anti-infective, Pain & Inflammation, Topical Antibiotics, Antiacne, Paediatrics, Dermatology and Diabetic segments. Wallace reaches out to over 100,000 medical practitioners and 35,000 retail chemists in India. Wallace formulations can also be found in many countries around Asia and Africa.

Wockhardt

www.wockhardtin.com

Wockhardt is a global, pharmaceutical and biotechnology company that has grown by leveraging two powerful trends impacting the world of medicine - globalisation and biotechnology. Wockhardt today, is distinguished by a strong and growing presence in the world’s leading markets. Wockhardt’s market presence covers formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients (APIs). Wockhardt’s manufacturing facilities in India, UK, Ireland, France and US have the approval of major regulatory bodies, including US FDA and UK's MHRA, with capabilities for both Finished Dosage Formulations and APIs. The output include Steriles (Injectables), Biopharmaceuticals, Orals (Tablets & Liquids), Topicals (Creams & Ointments).